Assenagon Asset Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Assenagon Asset Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-162,559	Closed	-$1.73M	–	1421
2023 Q2	$1.73M	Buy	162,559 +5,055	+3%	+$54.3K	0.01%	834
2023 Q1	$1.66M	Buy	157,504 +20,575	+15%	+$230K	0.01%	903
2022 Q4	$1.7M	Sell	136,929 -10,707	-7%	-$121K	0.01%	862
2022 Q3	$1.53M	Buy	147,636 +11,527	+8%	+$131K	0.01%	789
2022 Q2	$1.57M	Buy	+136,109	New	+$1.6M	0.01%	928
2022 Q1	–	Sell	-193,514	Closed	-$2.26M	–	1491
2021 Q4	$2.26M	Sell	193,514 -63,200	-25%	-$775K	0.01%	776
2021 Q3	$3.35M	Sell	256,714 -20	-0%	-$258	0.01%	536
2021 Q2	$3.3M	Hold	256,734	–	–	0.01%	573
2021 Q1	$2.87M	Buy	+256,734	New	+$2.71M	0.01%	630

Other funds holding IRWD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Assenagon Asset Management's IRWD Position: Q3 2023 in Review

Assenagon Asset Management sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2023, closing a stake of 162,559 shares — an estimated $1.73M sold.

Assenagon Asset Management first reported a position in IRWD in Q1 2021 and held it in 9 quarters. The position peaked at $3.35M in Q3 2021. 248 funds tracked by Wall St. Rank hold IRWD as of Q3 2023.

Assenagon Asset Management reported no remaining Ironwood Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
Assenagon Asset Management sold 162,559 Ironwood Pharmaceuticals shares in Q3 2023, an estimated $1.73M.
Assenagon Asset Management first reported a position in Ironwood Pharmaceuticals in Q1 2021 and held it in 9 quarters.
Assenagon Asset Management's Ironwood Pharmaceuticals position peaked at $3.35M in Q3 2021.
248 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2023.

Based on Assenagon Asset Management's 13F filing for Q3 2023, filed 6 Nov 2023.